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Abstract
Background: The prevalence of cardio-metabolic syndrome (CMS) is increasing worldwide. In people of African
descent, there is higher prevalence of hypertension and complications than other races. Bearing in mind these
facts, we looked at the CMS in the general population and the population with hypertension. Using the new
International Diabetes Federation (IDF) definitions of CMS, we studied its prevalence in semi-urban and rural
communities in South-east Nigeria in relation to hypertension.
Method: This is a cross sectional population based study involving 1458 adults aged from 25 to 64 years.
Diagnosis of CMS was based on the new IDF criteria using the anthropometric measurements for Europids as there
is none yet for blacks. Hypertension was defined according to the WHO/ISH criteria.
Results: The overall prevalence of CMS was 18.0% in the semi-urban community as against 10.0% in the rural
community increasing to 34.7% and 24.7% respectively in the population with hypertension. The prevalence of
co-morbidities - hyperglycaemia, abdominal obesity, and hypertriglceridaemia were 13.9%, 41.1% and 23.9% while
in the hypertensive populations they were 21.2%, 55.0% and 31.3% in the general population in both communities
combined. Except for low HDL cholesterol, every other co-morbidity was higher in hypertensive population than
the general population.
Conclusion: The high prevalence of CMS in the semi-urban population especially for the population with
hypertension underscores the double burden of disease in developing countries. The lesson is while infections and
infestations are being tackled in these countries the non-communicable diseases should not be neglected.
Background
The prevalence of cardio-metabolic syndrome (CMS) is
increasing worldwide; indeed it’s occurrence has been
described as a global epidemic [1]. The Third Report of
the National Cholesterol Education Program Expert
Panel (NCEP) on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults (ATP III) found that
ethnicity influences the prevalence of metabolic syn-
drome [2]. Mexican Americans are now known to have
the highest age-adjusted prevalence of metabolic syn-
drome for both men and women, and African-American
women have a higher incidence of metabolic syndrome
than African-American men [2,3]. Also, in people of
African descent there is higher prevalence of hyperten-
sion and complications than other races [4].
Current knowledge suggests the importance of
increased body mass index (BMI) especially visceral fat
in the pathophysiology of hypertension [5]. Some recent
studies suggested that CMS can predict the development
of hypertension [6]. CMS is characterized by the cluster
of physical and biochemical abnormalities in an indivi-
dual which predisposes the person to increased risk of
developing cardiovascular disease and it is also predic-
tive of future diabetes mellitus [7]. CMS and some of its
components are related to diet [8]. The average staple
diet of the rural African population consists mostly of
carbohydrate (70%) with rather low protein intake. It
has high fibre content, moderate oil mostly in form of
palm oil and average salt. In the semi-urban population
many have adopted western diet including fast foods
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and has average fibre content.
It is important therefore to investigate the presence of
CMS in patients with hypertension who may indeed be at
risk of diabetes mellitus in the future as well as its asso-
ciation with increased cardiovascular morbidity and mor-
tality. Bearing in mind these facts; we looked at the CMS
in the general population and the population with hyper-
tension. Using the new International Diabetes Federation
(IDF) definitions of CMS, we studied its prevalence in
semi-urban and rural communities in South-east Nigeria.
Method
Study Area
N i g e r i ai sm a d eu po f6g e o - p o litical zones with a total
of 36 states and the Federal Capital Territory. The
South East zone comprises of 5 states (Enugu, Ebonyi,
Imo, Abia and Anambra) with estimated population of
30 million people. They are Igbo speaking and the zone
is located between latitude 5° - 7° North of the Equator
and longitude 6° - 8° East Greenwich.
The study area is Ujodo Nike Local Government
Development Centre (LGDC) in Enugu North Local
Government Area (LGA) of Enugu State. This LGDC
comprises of three communities namely Mbulu-Ujodo,
Mbulu-Awuli and Emene communites. Emene-Nike was
chosen as the only semi-urban area and Mbulu-Ujodo
was randomly selected from the two rural communities.
Mbulu-Ujodo comprises of villages or hamlets viz.: Obi-
nagu, Nchantancha, Akpuoga and Onuogba.
Study Population
In the rural community many young people have
migrated to the cities leaving a preponderance of rela-
tively elderly population. They are mostly of low socio-
economic status engaging mainly in farming. In the
semi-urban community most inhabitants in the study
area are individuals with low socio-economic status
mainly artisans, traders and low income workers who
live in over-crowded homes with poor sanitary condi-
tions. This study population by culture and ancestry
believe in the healing powers of their gods and their
chief priests and the native doctors hence the use of
native medications is very common. Most individuals
would try alternative medicine and spiritual healing
homes before presenting to hospitals [9]. Apart from
consulting native doctors/healers, patronage of patent
medicine dealers and laboratory scientists is rampant.
This is because of inability to afford cost of health care
services. In the Igbo tribe, being overweight/obese is
preferred and use of mercury containing soaps and
bleaching cream to achieve fair skin complexion is
encouraged as these features, are seen as marks of
beauty [10].
Sample size, Frame, Design and Selection
A minimum target sample size of 2000 adults aged 25 to
64 stratified by sex and 10-year age group as per modi-
fied WHO STEPS[11] surveillance and Program for
Detection and Management of Chronic Kidney Disease,
Hypertension, Diabetes and Cardiovascular Disease in
Developing Countries (KHDC)[12] questionnaires was
used. To compensate for anticipated non-response or
attrition, the number was projected to 2200.
Emene, Nike has a population of 70,000 and Mbulo-
Ujodo, Nike has a population of 40,000. Since the cur-
rent census list (2006 census list) was not yet in public
purview, enumeration was done. Two thirds were
selected from the semi-urban area and the remaining
third from the rural community to achieve proportional
representation.
Study Personnel
The personnel were made up of doctors, nurses, medical
students, social workers, sociologists and laboratory
technologists drawn from the staff of Departments of
Medicine and Pharmacology, College of Medicine, Uni-
versity of Nigeria Teaching Hospital (UNTH), Enugu,
Nigeria.
Questionnaire and Consent form
T h eq u e s t i o n n a i r ew a sah y b r i do ft h eW H OS T E P S
[11] and the KHDC[12] questionnaires with some addi-
tional questions to address the peculiarities in the locale
of the study. The questionnaire was translated to Igbo
language, the prevailing language spoken in the study
area. Self-reported history of alcohol consumption, use
of tobacco as snuff or cigarette or any other form of
tobacco as well as family, present and past histories of
hypertension, diabetes mellitus, renal disease and stroke/
heart attack were obtained from the respondents.
Ethical Review
The project proposal, the modified questionnaire and
the consent form were reviewed and approved by the
University of Nigeria Teaching Hospital, Enugu, Ethics
Review Committee.
Clinical Evaluation and Collection of Samples
The Clinical evaluation and collection of samples were
carried out at screening centres set-up at spots conveni-
ent for the participants: churches, market square, town
hall and the Health Centre at Akpuoga, Nike.
The participants’ anthropometric data were taken:
height, weight, waist and hip circumferences. The weight
was measured using standardized bathroom scale (10 kg
weight was used). The heights were measured with a
standiometer. The waist circumference was taken at
mid-way between the sub-costal margin and the iliac
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widest diameter. The blood pressure measurements
were taken three times in the arm with the participants
sitting using Accusson’s mercury sphygmomanometer
with appropriate cuff sizes. Three milliliters of fasting
blood was taken into plain bottle for blood chemistry
(lipids) -total cholesterol (TC), low density lipoprotein
cholesterol (LDL-C), high density lipoprotein cholesterol
(HDL-C) and triglycerides (TGs). Blood sugar was done
with Accuchek glucometer. All samples were analyzed
at the Dept of Medicine Research Laboratory, University
of Nigeria Teaching Hospital, Enugu. The TC and TGs
were measured by enzymatic colorimetric method and
HDL- C and LDL-C by differential precipitation enzy-
matic colorimetric using semi-autoanalyser Mitra Photo-
meter (Linear Chemicals S.L., Barcelona, Spain). All
parameters were expressed as mmol/l.
Definitions
Diagnosis of CMS was based on the new International
Diabetes Federation (IDF) criteria[13] using the anthro-
pometric measurements for Europids as there are none
yet for blacks. As defined by IDF: central obesity - waist
circumference ≥ 94 cm for men and ≥ 80 cm for
women. Plus any two of the following factors:
￿ raised TG level - ≥ 1.7 mmol/l or specific treat-
ment for this lipid abnormality
￿ reduced HDL - cholesterol - < 1.03 mmol/l in
males and < 1.30 mmol/l in females or specific treat-
ment for this lipid abnormality
￿ raised blood pressure - systolic ≥ 130 mmHg or
diastolic ≥ 85 mmHg or treatment of previously
diagnosed hypertension
￿ raised fasting blood sugar - ≥ 5.6 mmol/l or pre-
viously diagnosed type 2 DM
Hypertension was defined as systolic blood pressure ≥
140 mmHg or diastolic blood pressure ≥ 90 mmHg or
both and/or concomitant use of antihypertensive medi-
cations according to the WHO/ISH guidelines[14].
Statistical Analysis
The Statistical Package for Social Sciences (SSPS Inc,
Chicago, IL) version 16 statistical software was used for
data analysis. Cross tabulation was used to determine
the prevalence of metabolic syndrome and the individual
components of metabolic syndrome in the communities.
We examined the relationship between the various vari-
ables such as sex, age, level of education or years in
school, site (semi-urban or rural community), abdominal
obesity, present history of hypertension and DM in both
communities. The use of tobacco was examined by
using ‘ever used’ or ‘never used’ tobacco status. And we
assessed alcohol consumption by number of drinks
taken (<2 or >2).
All tests were two-tailed with p < 0.05 taken as statis-
tically significant.
Results
A total of 1939 were analyzed out of 2182 individuals
who were screened. The others could not be analyzed
because of incomplete data. Of the 1939 participants,
about 500 female participants were removed to avoid
skewing the data leaving a total of 1458. This was done
by removing the women recruited towards the end of
the study.
Demographic Characteristics
Table 1 shows the demography of the study population
including the mean ages of the participants in the rural
and semi-urban communities. The mean age for study
population was 43.8 ± 13.7 years (male respondents -
44.1 ± 14.2 years; female respondents - 43.4 ± 13.2
years, p = 0.35). The mean age of the participants with
CMS (48.1 ± 11.1 years) was significantly higher than
that of the participants without CMS (42.8 ± 13.9
years), p < 0.001.
Prevalence of Hypertension and CMS
Table 2 shows the characteristics of the study popula-
tion - semi-urban and rural communities. The overall
prevalence of CMS was 18.0% in the semi-urban com-
munity as against 10% in the rural community increas-
ing to 34.7% and 24.7% respectively in the population
with hypertension. The prevalence of hypertension was
35.4% in the semi-urban community as against 25.1% in
Table 1 Demographic characteristics of the study
population
Characteristics Semi-urban
(1088)
Rural
(370)
All
(1458)
p-
value
Men (%) 49.6 45.7 48.6 0.188
Mean age 42.3 ± 13.5 48.2 ±
13.2
43.8 ±
13.7
<0.001*
Age group(%): - - - -
25 - 34 years 36.5 20.0 32.3 -
35 - 44 years 17.5 14.1 16.6 <0.001*
45 - 54 years 21.6 27.9 22.4 -
55 - 64 years 24.4 41.4 28.7 -
Number of years in
School
-- - -
(%): - - - -
No formal schooling 14.5 55.1 24.8 -
≤ 6 years 21.7 25.1 22.6 -
7 - 12 years 32.9 15.9 28.6 <0.001*
>12 years 30.9 3.8 24.0 -
*- p-value: significant
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of CMS and hypertension were 15.9% and 32.8%
respectively.
Prevalence of Components of CMS
The prevalence rates of CMS and other co-morbidities
such as abdominal obesity, hyperglycaemia (fasting
blood sugar ≥ 5.6 mmol/l), hypertriglyceridaemia and
low HDL cholesterol in the general and hypertensive
populations in the communities are as shown in
Table 3. Except for low HDL every other co-morbidity
was higher in hypertensive population than the general
population. Overall, blood pressure (using cut-off for
CMS) had the highest prevalence being 42.3%, followed
by abdominal obesity - 41.1%. The hypertensive popula-
tion as expected had significantly higher prevalence
rates than the general population except for low HDL-C.
The prevalence of main population health determi-
nants (which are also part of the natural history of CMS
and hypertension) such as tobacco use, alcohol con-
sumption and physical inactivity are as displayed in
Table 4. The prevalence of CMS increased up until age
44 - 54 years and then declined while the prevalence of
hypertension showed continuous increase to age group
55 - 64 years. The prevalence of hypertension increased
with the number of MS risk factors, Fig. 1.
Discussion
Demographic and Anthropometric Characteristics
The study has shown a larger proportion of young peo-
ple (age group 25 - 34 years) - 36.5% in the semi-urban
area while the older people were more predominant in
rural community (age group 55 - 64 years) - 41.4%. This
age disparity in population distribution reflects the trend
of rural-urban migration that is common in Nigeria.
The semi-urban community recorded a higher percen-
tage for the two indices for assessment of obesity i.e.
waist circumference and BMI (female 70.7%, male 16.7%
and 19.2% respectively) than for the rural community
Table 2 Anthropometric characteristics, Physical Activity
and Prevalence of CMS and Hypertension in study
population
Semi-urban
(1088)
Rural
(370)
All
(1458)
p-
value
BMI (%): - - - -
≥ 25 to <30 kg/m
2 33.1 27.1 31.6 0.032*
≥ 30 kg/m
2 19.2 11.7 17.3 0.001*
Waist circumference
(%):
-- - -
≥ 80 cm female 70.7 53.7 66.0 <0.001*
≥ 94 for male 16.7 8.9 14.9 0.014*
Physical activity (%) 94.5 99.1 95.8 <0.001*
MS 18.00 10.00 15.9 <0.001*
Hypertension 35.4 25.1 32.8 <0.001*
*- p-value: significant
Table 3 Prevalence of co-morbidities in non-hypertensive, hypertensive and general populations in the various
communities
MS Hyperglycaemia
(≥ 5.6 mmol/l)
Abdominal obesity
$TC> >6.2 mmol *TG ≥ >1.70 mmol
#HDL
Rural NHP 5.1 12.2 20.1 4.7 13.7 33.9
HP 24.7 23.0 34.4 9.7 22.6 41.3
GP 10 14.9 28.2 5.9 15.9 35.8
ORs 6.12 2.15 1.49 2.18 1.83 1.37
(95% CI) (3.02 - 12.62) (1.15 - 3.99) (0.90 - 2.46) (0.90 - 5.27) 1.01-3.32 (0.84 - 2.22)
p-value <0.001 0.014 0.12 0.79 0.043 0.20
Semi- urban NHP 8.8 9.6 35.2 5.7 23.1 33.8
HP 34.7 20.7 57.1 10.8 33.4 27.7
GP 18.0 13.6 43.7 7.5 26.7 31.7
Ors
(95% CI)
5.52
(3.94 - 7.74)
2.45
(1.69 - 3.57)
2.66
(2.07 - 3.45)
1.99
(1.26 - 3.16)
1.67
(1.26 - 2.21)
0.75
(0.57 - 0.99)
p-value <0.001 <0.001 <0.001 0.003 <0.001 <0.043
Both communities NHP 7.7 10.4 34.3 5.4 20.4 33.9
HP 32.8 21.2 55.0 10.6 31.3 30.4
GP 15.9 13.9 41.1 7.1 23.9 32.7
Ors
(95% CI)
5.82
(4.30 - 7.89)
2.32
(1.69 - 3.18)
2.35
(1.88 - 2.94)
2.06
(1.37 - 3.09)
1.78
(1.38 - 2.28)
0.85
(0.67 -1.09)
p-value <0.001 <0.001 <0.001 <0.001 <0.001 0.20
Key:
$- total cholesterol; *- triglyceride;
# - 1.03 mmol/l in males & <1.3 mmol/l in females; NHP non-hypertensive population; HP- population with hypertension;
GP- general population; *- p-value: significant
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of the adoption of western life style in semi-urban com-
munity compared to the rural community. A study in
Seychelles by Kelliny et al noted: female 75.6%, male
35.8% for waist circumference and 26.9% for BMI [15].
While in Cameroun, Fezeu at al documented prevalence
rates of 20.5% and 10.9% of obesity using BMI in urban
and rural populations respectively [16].
CMS in Rural versus Semi-urban Communities
Our study has demonstrated a high prevalence of cardio-
metabolic syndrome in the semi-urban community
(18.0%) though not as high as in many developed coun-
tries. This observation is of concern. The prevalence of
CMS in the semi-urban community is about double that
recorded for the rural community (10.0%). Information on
population-based study on CMS in Africa is sparse. How-
ever, Fezeu et al [16] recorded much lower values than in
our study: 1.8% for rural community and 5.9% for urban
community. The higher value recorded in our study may
suggest that Nigeria is in transition phase between the tra-
ditional African culture and western culture. A study in
South Africa [17] looking at corporate executives found a
prevalence of 31% using ATP III. Another study in the US,
of African Americans aged 35-84 years, recorded a preva-
lence of metabolic syndrome of 43.3% in women and
32.7% in men [18]. Studies in US [19], and Europe [20]
have documented 34%, and 29.6% respectively.
The finding of high percentage of CMS in this study is
of clinical and public health importance as metabolic
syndrome is an important risk factor for diabetes, cor-
onary heart disease, stroke and CKD. Furthermore, in
Nigeria like in most developing countries public aware-
ness of the dangers western life style pose to health is
limited. Studies in some other developing countries have
noted high prevalence of CMS similar to or even higher
than what obtains in developed countries [7,15,21]. In
C h i l e ,t h e yn o t e dap r e v a l e n c eo f3 1 . 6 %f o rg e n e r a l
population and 61.6% for hypertensive population [7].
These are way above 15.9% and 32.8% noted respectively
for general and hypertensive populations in this present
study. Albeit, the implication of this trend in developing
countries is ominous because of the poor state of health
services and associated high prevalence of communic-
able diseases. These bring the double burden of disease
as emphasized by World Health Organization to the
fore [22].
Prevalence of Components of CMS
Visceral fat has been described as an endocrine organ
secreting adipocytokines which are aetiologically related
to CMS [23] and hypertension [24]. Apart from blood
pressure which had a prevalence of 42.3%, abdominal
obesity had a high prevalence of 41.1%. In Cameroun,
Fezeu et al [16] identified central obesity as the key
determinant factor for CMS in that population. How-
ever, in Chile [7], they noted higher prevalence of 46%
for elevated blood pressure and 29% for abdominal obe-
sity. We used IDF definition of CMS in this present
study while the Chilean study used the updated ATP III.
This could in part explain the difference but in Sey-
chelles, they documented 55.8% and 61.5% using IDF
and ATP III definitions for abdominal obesity [15].
As expected the prevalence of hypertension increased
with age. It is noted in JNC VI that by age 65 years
more than two thirds of individuals already have hyper-
tension [25]. On the other hand the prevalence of CMS
in this present study increased up until age group 45 to
54 years and then declined. This may be related to the
loss of body fat with aging in this population. Kelliny
et al made similar observation but it was only in the
male population using ATP III definition [15]. Most
other studies show continuous increase of prevalence
with age [19-21].
Table 4 Prevalence of population health determinants in general and hypertensive populations in the communities
Health determinants Semi Urban Community % ORs (95% CI) P-value Rural Community % ORs (95% CI) p-value
NHP HP GP NHP HP GP
Tobacco use 12.3 18.9 14.6 1.65 (1.15 - 2.39) 0.007* 14.8 17.7 15.5 1.24 (0.64 - 2.44) 0.535
Alcohol use 61.9 55.8 59.9 0.78 (0.58 - 1.03) 0.083 64.9 69.8 66.1 1.25 (0.68 - 2.13) 0.473
Inactivity 4.0 8.4 5.5 0.45 (0.26 - 0.79) 0.004* 0.7 1.1 0.82 0.67 (0.06 - 7.47) 0.741
Key: NHP - non-hypertensive population; HP - population with hypertension; GP - general population; * - p-value: significant
Figure 1 Prevalence of hypertension by number of
components of MS.
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Though this study is population-based, looking at rural
and semi-urban communities, there were some limita-
tions. The cross sectional design of the study.
The use of self report for alcohol consumption and
use of tobacco, being mostly illiterate and semi-literate
population the accuracy of their reporting may be
questioned.
Conclusion
The prevalence of MS in this study was high especially
when compared with figures from Cameroun [16], a
neighbouring country. This high prevalence of MS in
the semi-urban population especially for the population
with hypertension underscores the double burden of
disease in developing countries. While infections and
infestations are being tackled in these countries the
non-communicable diseases should not be neglected.
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